PepperLime Health Acquisition Corporation Unit
PEPLU
PEPLU was delisted on the 19th of January, 2024.
6 hedge funds and large institutions have $1.76M invested in PepperLime Health Acquisition Corporation Unit in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 6 closing their positions.
45% less funds holding
Funds holding: 11 → 6 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
88% less capital invested
Capital invested by funds: $15.1M → $1.76M (-$13.3M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.87K |
Top Sellers
PEPLU Hedge Fund Activity: Q4 2022 in Review
6 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in PepperLime Health Acquisition Corporation Unit (PEPLU) for Q4 2022, worth a combined $1.76M — down 88% from $15.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PEPLU and 1 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $1.87K. The largest seller was Sandia Investment Management, exiting entirely with an estimated $9.75M sold.
- 6 institutional investors held PepperLime Health Acquisition Corporation Unit (PEPLU) as of Q4 2022, down from 11 in Q3 2022.
- Funds reported $1.76M of PepperLime Health Acquisition Corporation Unit stock for Q4 2022, down 88% quarter-over-quarter.
- 1 fund opened new PepperLime Health Acquisition Corporation Unit positions in Q4 2022 and 6 closed out, a net change of -5 holders.
- The largest PepperLime Health Acquisition Corporation Unit buyer in Q4 2022 was UBS Group, an estimated $1.87K added.
- The largest PepperLime Health Acquisition Corporation Unit seller in Q4 2022 was Sandia Investment Management, an estimated $9.75M sold.
Based on aggregated 13F filings for Q4 2022.